AU8633082A - Paramagnetic complex salts and their use in nmr- diagnostics - Google Patents

Paramagnetic complex salts and their use in nmr- diagnostics

Info

Publication number
AU8633082A
AU8633082A AU86330/82A AU8633082A AU8633082A AU 8633082 A AU8633082 A AU 8633082A AU 86330/82 A AU86330/82 A AU 86330/82A AU 8633082 A AU8633082 A AU 8633082A AU 8633082 A AU8633082 A AU 8633082A
Authority
AU
Australia
Prior art keywords
numbers
see diagramm
diagnostics
nmr
paramagnetic complex
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU86330/82A
Other versions
AU566007B2 (en
Inventor
Heinz Gries
Douwe Rosenberg
Hans-Joachim Weinmann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6137999&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AU8633082(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering AG filed Critical Schering AG
Publication of AU8633082A publication Critical patent/AU8633082A/en
Application granted granted Critical
Publication of AU566007B2 publication Critical patent/AU566007B2/en
Anticipated expiration legal-status Critical
Expired legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
    • G01R33/00—Arrangements or instruments for measuring magnetic variables
    • G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
    • G01R33/44—Arrangements or instruments for measuring magnetic variables involving magnetic resonance using nuclear magnetic resonance [NMR]
    • G01R33/48—NMR imaging systems
    • G01R33/54—Signal processing systems, e.g. using pulse sequences ; Generation or control of pulse sequences; Operator console
    • G01R33/56—Image enhancement or correction, e.g. subtraction or averaging techniques, e.g. improvement of signal-to-noise ratio and resolution
    • G01R33/5601—Image enhancement or correction, e.g. subtraction or averaging techniques, e.g. improvement of signal-to-noise ratio and resolution involving use of a contrast agent for contrast manipulation, e.g. a paramagnetic, super-paramagnetic, ferromagnetic or hyperpolarised contrast agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/3804—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
    • C07F9/3839—Polyphosphonic acids
    • C07F9/386—Polyphosphonic acids containing hydroxy substituents in the hydrocarbon radicals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
    • G01R33/00—Arrangements or instruments for measuring magnetic variables
    • G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
    • G01R33/28—Details of apparatus provided for in groups G01R33/44 - G01R33/64
    • G01R33/281—Means for the use of in vitro contrast agents

Landscapes

  • Physics & Mathematics (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • General Physics & Mathematics (AREA)
  • Condensed Matter Physics & Semiconductors (AREA)
  • Biochemistry (AREA)
  • High Energy & Nuclear Physics (AREA)
  • Signal Processing (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Optics & Photonics (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

1. The use of at least one physiologically tolerable paramagnetic complex salt made from aminopolycarboxylic acids having the formulae I to IV see diagramm : EP0169299,P6,F1 N-hydroxyethyl-N,N',N'-ethylenediaminetriacetic acid (HEDTA), see diagramm : EP0169299,P6,F2 N,N,N',N",N"-diethylenetriaminepenta-acetic acid (DTPA), HOH2 C-CH2 N(CH2 COOH)2 N-hydroxyethylimino-diacetic acid, see diagramm : EP0169299,P6,F3 wherein m represents the numbers 1 to 4, n the numbers 0 to 2, R**1 a saturated or unsaturated hydrocarbon radical having from 4 to 12 hydrocarbon atoms or the group -CH2 -COOH, and from the ions of the lanthanide elements having the atomic numbers 57 to 70 or from the ions of the transition metals having the atomic numbers 21 to 29, 42 and 44 and, optionally from an inorganic base for the preparation of agents for NMR diagnostics.
AU86330/82A 1981-07-24 1982-07-22 Paramagnetic complex salts and their use in nmr- diagnostics Expired AU566007B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3129906A DE3129906C3 (en) 1981-07-24 1981-07-24 Paramagnetic complex salts, their preparation and agents for use in NMR diagnostics
DE31299067 1981-07-24

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU10186/88A Division AU601916B2 (en) 1981-07-24 1988-01-08 Paramagnetic complex salts, their preparation and their use in nmr-diagnostics

Publications (2)

Publication Number Publication Date
AU8633082A true AU8633082A (en) 1983-01-27
AU566007B2 AU566007B2 (en) 1987-10-08

Family

ID=6137999

Family Applications (2)

Application Number Title Priority Date Filing Date
AU86330/82A Expired AU566007B2 (en) 1981-07-24 1982-07-22 Paramagnetic complex salts and their use in nmr- diagnostics
AU10186/88A Expired AU601916B2 (en) 1981-07-24 1988-01-08 Paramagnetic complex salts, their preparation and their use in nmr-diagnostics

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU10186/88A Expired AU601916B2 (en) 1981-07-24 1988-01-08 Paramagnetic complex salts, their preparation and their use in nmr-diagnostics

Country Status (12)

Country Link
EP (2) EP0169299B1 (en)
JP (3) JPS5829718A (en)
AT (2) ATE52247T1 (en)
AU (2) AU566007B2 (en)
CA (2) CA1218597A (en)
DE (3) DE3129906C3 (en)
IE (1) IE53639B1 (en)
LU (1) LU88291I2 (en)
NL (1) NL930072I2 (en)
NO (2) NO164458C (en)
NZ (1) NZ201372A (en)
ZA (1) ZA825313B (en)

Cited By (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1986001112A1 (en) * 1984-08-10 1986-02-27 Fox Chase Cancer Center Magnetic micro-particles as contrast agents in nuclear magnetic resonance imaging
WO1986002841A1 (en) * 1984-11-13 1986-05-22 New Salutar, Inc. Diamide-dtpa-paramagnetic contrast agents for mr imaging, apparatus and methods
US4615879A (en) * 1983-11-14 1986-10-07 Vanderbilt University Particulate NMR contrast agents for gastrointestinal application
WO1986006605A1 (en) * 1985-05-08 1986-11-20 The General Hospital Corporation Hepatobiliary nmr contrast agents
US4637929A (en) * 1985-01-04 1987-01-20 Salutar, Inc. Ferrioxamine-paramagnetic contrast agents for MR imaging, composition, apparatus and use
US4687658A (en) * 1984-10-04 1987-08-18 Salutar, Inc. Metal chelates of diethylenetriaminepentaacetic acid partial esters for NMR imaging
US4746507A (en) * 1985-04-02 1988-05-24 Salutar, Inc. EDHPA based contrast agents for MR imaging, apparatus and methods
US4749560A (en) * 1984-08-13 1988-06-07 Research Corporation Metal organo phosphorous compounds for NMR analysis
AU573611B2 (en) * 1983-08-12 1988-06-16 Du Pont Merck Pharmaceutical Company, The Nmr imaging utilizing chemical shift reagents
US4758422A (en) * 1985-01-04 1988-07-19 Salutar Inc. Ferrioxamine paramagnetic contrast agents for MR imaging
US4808541A (en) * 1983-03-15 1989-02-28 Lkb Produkter Ab Determination method utilizing reagents covalently labelled with essentially non-fluorescent lanthanide chelates in combination with time-resolved fluorescence spectroscopy and the reagents to be used in the method
AU583070B2 (en) * 1984-11-23 1989-04-20 Schering Aktiengesellschaft Magnetic particles for diagnostic purposes
US4859450A (en) * 1984-08-13 1989-08-22 The General Hospital Corporation Method of NMR imaging using antibody to cardiac myosin
US4859451A (en) * 1984-10-04 1989-08-22 Salutar, Inc. Paramagnetic contrast agents for MR imaging
US4880008A (en) * 1985-05-08 1989-11-14 The General Hospital Corporation Vivo enhancement of NMR relaxivity
US4885363A (en) * 1987-04-24 1989-12-05 E. R. Squibb & Sons, Inc. 1-substituted-1,4,7-triscarboxymethyl-1,4,7,10-tetraazacyclododecane and analogs
US4925652A (en) * 1983-08-03 1990-05-15 Schering Aktiengesellschaft Nitroxyl compounds, and diagnostic media based thereon useful for enhancing NmR imaging
US4972837A (en) * 1983-04-26 1990-11-27 Regents Of The University Of California Contrast agents for nuclear magnetic resonance imaging
US4985233A (en) * 1984-11-01 1991-01-15 Nycomed /As A diagnostic agent containing a non-radioactive paramagnetic metal species in a macromolecular carrier
US4986980A (en) * 1984-11-01 1991-01-22 Nycomed As Water-soluble, carrier-bound paramagnetic metal containing diagnostic agents
US5010191A (en) * 1985-08-19 1991-04-23 The Regents Of The University Of California Imaging agents for in vivo magnetic resonance and scintigraphic imaging
US5089644A (en) * 1985-01-04 1992-02-18 Salutar Inc. Preparation of oxamine complexes
US5208324A (en) * 1988-01-26 1993-05-04 Nycomed Imaging As Paramagnetic compounds
US5474756A (en) * 1986-01-23 1995-12-12 Bracco International B.V. Method for imaging mammalian tissue using 1-substituted-1,4,7-tricarboxymethyl-1,4,7,10-tetraazacyclododecane and analogs
US5582814A (en) * 1994-04-15 1996-12-10 Metasyn, Inc. 1-(p-n-butylbenzyl) DTPA for magnetic resonance imaging
US5618514A (en) * 1983-12-21 1997-04-08 Nycomed Imaging As Diagnostic and contrast agent
US5665328A (en) * 1988-05-02 1997-09-09 Phanos Technologies, Inc. Compounds, compositions and methods for binding bio-affecting substances to surface membranes of bio-particles
US5720939A (en) * 1985-08-15 1998-02-24 Nycomed Imaging As Method of contrast enhanced magnetic resonance imaging using magnetically responsive-particles
US6193950B1 (en) 1989-11-21 2001-02-27 Schering Ag Cascade polymer bound complexing compounds, their complexes and conjugates, processes for their production, and pharmaceutical agents containing them
US6676929B2 (en) 1995-02-01 2004-01-13 Epix Medical, Inc. Diagnostic imaging contrast agents with extended blood retention
US7811570B2 (en) 1992-04-07 2010-10-12 Immunomedics, Inc. Method of affecting a function of or ablating a non-malignant cell
CN103664672A (en) * 2013-10-21 2014-03-26 河北一品制药有限公司 Industrial preparation method of high-purity gadopentetate dimeglumine

Families Citing this family (104)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3129906C3 (en) * 1981-07-24 1996-12-19 Schering Ag Paramagnetic complex salts, their preparation and agents for use in NMR diagnostics
US4957939A (en) * 1981-07-24 1990-09-18 Schering Aktiengesellschaft Sterile pharmaceutical compositions of gadolinium chelates useful enhancing NMR imaging
NL194579C (en) * 1983-01-21 2002-08-05 Schering Ag Diagnostic.
DE3448606C2 (en) * 1983-01-21 2001-12-13 Schering Ag Diagnostic agents, processes for their production and their use
US4735796A (en) * 1983-12-08 1988-04-05 Gordon Robert T Ferromagnetic, diamagnetic or paramagnetic particles useful in the diagnosis and treatment of disease
EP0330801A1 (en) * 1983-02-08 1989-09-06 Schering Aktiengesellschaft Ferromagnetic, diamagnetic or paramagnetic particles useful in the diagnosis and treatment of disease
DE3316703A1 (en) * 1983-05-04 1984-11-08 Schering AG, 1000 Berlin und 4709 Bergkamen ORAL CONTRAST AGENT FOR MRI MRI AND THE PRODUCTION THEREOF
DE3324235A1 (en) * 1983-07-01 1985-01-10 Schering AG, 1000 Berlin und 4709 Bergkamen NEW COMPLEX ILLUMINATORS, COMPLEX AND COMPLEX SALTS
FR2550449B1 (en) * 1983-08-12 1986-01-31 Commissariat Energie Atomique SPECIFIC ORGAN OR PATHOLOGY RELAXATION AGENTS FOR USE IN MODIFYING CONTRASTS IN MEDICAL IMAGING BY NUCLEAR MAGNETIC RESONANCE
CA1243602A (en) * 1983-08-25 1988-10-25 Hong-Ning Yeung Methods for enhancing the contrast in nmr imaging
GB8408127D0 (en) * 1984-03-29 1984-05-10 Nyegaard & Co As Contrast agents
US4728575A (en) * 1984-04-27 1988-03-01 Vestar, Inc. Contrast agents for NMR imaging
GB8413772D0 (en) * 1984-05-30 1984-07-04 Nyegaard & Co As Chemical compounds
GB8413849D0 (en) * 1984-05-31 1984-07-04 Amersham Int Plc Nmr contrast agents
US5316757A (en) * 1984-10-18 1994-05-31 Board Of Regents, The University Of Texas System Synthesis of polyazamacrocycles with more than one type of side-chain chelating groups
US4639365A (en) * 1984-10-18 1987-01-27 The Board Of Regents, The University Of Texas System Gadolinium chelates as NMR contrast agents
US5362476A (en) * 1984-10-18 1994-11-08 Board Of Regents, The University Of Texas System Alkyl phosphonate polyazamacrocyclic cheates for MRI
US5342606A (en) * 1984-10-18 1994-08-30 Board Of Regents, The University Of Texas System Polyazamacrocyclic compounds for complexation of metal ions
DE3508000A1 (en) * 1985-03-04 1986-09-04 Schering AG, Berlin und Bergkamen, 1000 Berlin Ferromagnetic particles for NMR diagnosis
DE3443251C2 (en) * 1984-11-23 1998-03-12 Schering Ag Iron oxide complexes for NMR diagnosis, diagnostic compounds containing these compounds, their use and process for their preparation
DE3443252A1 (en) * 1984-11-23 1986-05-28 Schering AG, 1000 Berlin und 4709 Bergkamen Dextran-magnetite complexes for NMR diagnosis
US4986256A (en) * 1985-02-28 1991-01-22 The United States Of America As Represented By The Department Of Health And Human Services Use of paramagnetic metalloporphyrins as contrast agents for tumors in MRI imaging
US5422096A (en) * 1985-05-08 1995-06-06 The General Hospital Corporation Hydroxy-aryl metal chelates for diagnostic NMR imaging
US4830847A (en) * 1985-06-28 1989-05-16 The Procter & Gamble Company Diphosphonate-derivatized macromolecules
US4735210A (en) * 1985-07-05 1988-04-05 Immunomedics, Inc. Lymphographic and organ imaging method and kit
GB8518300D0 (en) * 1985-07-19 1985-08-29 Amersham Int Plc Contrast agent
GB8522535D0 (en) * 1985-09-11 1985-10-16 Amersham Int Plc Contrast agent
US5336762A (en) * 1985-11-18 1994-08-09 Access Pharmaceuticals, Inc. Polychelating agents for image and spectral enhancement (and spectral shift)
EP0247156B1 (en) * 1985-11-18 1993-06-23 Access Pharmaceuticals Inc. Polychelating agents for image and spectral enhancement (and spectral shift)
DE3772785D1 (en) * 1986-01-23 1991-10-17 Squibb & Sons Inc 1-SUBSTITUTED-4,7,10-TRISCARBOXYMETHYL-1,4,7,10-TETRAAZACYCLODODECAN AND ANALOG.
IT1213029B (en) * 1986-01-30 1989-12-07 Bracco Ind Chimica Spa PARAMAGNETIC METAL ION CHELATES.
JPS62231168A (en) * 1986-03-21 1987-10-09 ハイブリテツク・インコ−ポレイテツド Improvement method for forming internal standard for analyzing analite-receptor
KR880701111A (en) * 1986-04-07 1988-07-25 제뜨랭 프랑쎄 Composition for use in tomometry
US5352432A (en) * 1986-07-03 1994-10-04 Advanced Magnetics, Inc. Hepatocyte specific composition and their use as diagnostic imaging agents
US5342607A (en) * 1986-07-03 1994-08-30 Advanced Magnetics, Inc. Receptor mediated endocytosis type magnetic resonance imaging contrast agents
US5679323A (en) * 1986-07-03 1997-10-21 Advanced Magnetics, Inc. Hepatocyte-specific receptor-mediated endocytosis-type compositions
AU608759B2 (en) * 1986-08-04 1991-04-18 Amersham Health Salutar Inc NMR imaging with paramagnetic polyvalents metal salts of poly-(acid-alkylene-amido)-alkanes
IL83966A (en) * 1986-09-26 1992-03-29 Schering Ag Amides of aminopolycarboxylic acids and pharmaceutical compositions containing them
US5672334A (en) * 1991-01-16 1997-09-30 Access Pharmaceuticals, Inc. Invivo agents comprising cationic metal chelators with acidic saccharides and glycosaminoglycans
US5707604A (en) * 1986-11-18 1998-01-13 Access Pharmaceuticals, Inc. Vivo agents comprising metal-ion chelates with acidic saccharides and glycosaminoglycans, giving improved site-selective localization, uptake mechanism, sensitivity and kinetic-spatial profiles
DE3640708C2 (en) * 1986-11-28 1995-05-18 Schering Ag Improved pharmaceuticals containing metals
GB8700431D0 (en) * 1987-01-09 1987-02-11 Amersham Int Plc Contrast agents
DE3709851A1 (en) * 1987-03-24 1988-10-06 Silica Gel Gmbh Adsorptions Te NMR DIAGNOSTIC LIQUID COMPOSITIONS
DE3710730A1 (en) * 1987-03-31 1988-10-20 Schering Ag SUBSTITUTED COMPLEX ILLUMINATORS, COMPLEX AND COMPLEX SALTS, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL AGENTS CONTAINING THEM
US4984573A (en) * 1987-06-23 1991-01-15 Hafslund Nycomed Innovation Ab Method of electron spin resonance enhanced magnetic resonance imaging
US5198208A (en) * 1987-07-16 1993-03-30 Nycomed Imaging As Aminopolycarboxylic acids and derivatives thereof
US5531978A (en) * 1987-07-16 1996-07-02 Nycomed Imaging As Aminopolycarboxylic acids and derivatives thereof
DE3724188C2 (en) * 1987-07-17 1995-05-18 Heinz Dr Gries Metal-containing oligosaccharide polysulfates, process for their preparation and pharmaceutical compositions containing them
DE3927444A1 (en) * 1989-08-16 1991-02-28 Schering Ag USE OF AMID COMPLEX COMPOUNDS
DE3806795A1 (en) * 1988-02-29 1989-09-07 Schering Ag POLYMER-TIED COMPLEX IMAGERS, THEIR COMPLEXES AND CONJUGATES, METHOD FOR THEIR PRODUCTION AND PHARMACEUTICAL AGENTS CONTAINING THEM
DE3809671A1 (en) * 1988-03-18 1989-09-28 Schering Ag PORPHYRINE COMPLEX COMPOUNDS, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL AGENTS CONTAINING THEM
GB8813144D0 (en) * 1988-06-03 1988-07-06 Nycomed As Compositions
GB8817137D0 (en) * 1988-07-19 1988-08-24 Nycomed As Compositions
US5137711A (en) † 1988-07-19 1992-08-11 Mallickrodt Medical, Inc. Paramagnetic dtpa and edta alkoxyalkylamide complexes as mri agents
DE4001655A1 (en) * 1990-01-18 1991-07-25 Schering Ag 6-RING MACROCYCLIC TETRAAZA COMPOUNDS, METHOD FOR PRODUCING THE SAME AND PHARMACEUTICAL PRODUCTS CONTAINING THEM
DE3825040A1 (en) * 1988-07-20 1990-01-25 Schering Ag, 13353 Berlin 5- OR 6-RING MACROCYCLIC POLYAZA COMPOUNDS, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL AGENTS CONTAINING THEM
WO1990001295A1 (en) * 1988-08-04 1990-02-22 Advanced Magnetics, Incorporated Receptor mediated endocytosis type mri contrast agents
GB8819753D0 (en) * 1988-08-19 1988-09-21 Nycomed As Apparatus
US5314681A (en) * 1988-12-23 1994-05-24 Nycomed Innovation Ab Composition of positive and negative contrast agents for electron spin resonance enhanced magnetic resonance imaging
GB8900719D0 (en) * 1989-01-13 1989-03-08 Nycomed As Compounds
FR2654344B1 (en) * 1989-11-16 1994-09-23 Cis Bio Int GADOLINIUM PARAMAGNETIC COMPLEX, ITS PREPARATION METHOD AND ITS USE FOR MRI DIAGNOSIS.
US5516503A (en) * 1989-11-16 1996-05-14 Guerbet S.A. Diagnostic composition comprising a binuclear complex, its method of preparation and its use in magnetic resonance imaging
ATE140869T1 (en) * 1989-11-27 1996-08-15 Concat Ltd QUALITY IMPROVEMENT OF MR IMAGES OF BONE AND SIMILAR TISSUE USING PARAMAGNETIC CATION COMPLEXES AND POLYPHOSPHONATE LIGANDS
CH679742A5 (en) * 1990-01-09 1992-04-15 Byk Gulden Lomberg Chem Fab
EP0511275A1 (en) * 1990-01-19 1992-11-04 Nycomed Imaging As Chelating compounds
FR2667506B1 (en) * 1990-10-05 1993-08-20 Medgenix Group Sa CONTRAST AGENT COMPRISING A PARAMAGNETIC CATION ASSOCIATED WITH A SCHIFF BASE.
FR2670113A1 (en) * 1990-12-06 1992-06-12 Medgenix Group Sa CONTRAST AGENT CONSTITUTED BY A NEUTRAL COMPLEX OF A PARAMAGNETIC CATION AND LIGAND TO FORM A COMPLEX.
US5143716A (en) * 1991-02-01 1992-09-01 Unger Evan C Phosphorylated sugar alcohols, Mono- and Di-Saccharides as contrast agents for use in magnetic resonance imaging of the gastrointestinal region
US5885549A (en) * 1991-02-01 1999-03-23 Imarx Pharmaceutical Corp. Phosphorylated materials as contrast agents for use in magnetic resonance imaging of the gastrointestinal region
US5360459A (en) 1991-05-13 1994-11-01 The Lubrizol Corporation Copper-containing organometallic complexes and concentrates and diesel fuels containing same
GB9208908D0 (en) * 1992-04-24 1992-06-10 Nycomed As Contrast agents
DE4302287A1 (en) * 1993-01-25 1994-07-28 Schering Ag Derivatized DTPA complexes, pharmaceutical compositions containing these compounds, their use and processes for their preparation
DE4340809C2 (en) * 1993-11-24 2000-08-03 Schering Ag 1.4,7,10-tetraazacyclododecane derivatives, pharmaceutical compositions containing them and process for their preparation
US6693190B1 (en) 1994-05-11 2004-02-17 Bracco International B.V. Enhanced relaxivity monomeric and multimeric compounds
US5672335A (en) * 1994-11-30 1997-09-30 Schering Aktiengesellschaft Use of metal complexes as liver and gallbladder X-ray diagnostic agents
DE19508058A1 (en) * 1995-02-21 1996-08-22 Schering Ag Process for the preparation of DTPA tetraesters of the terminal carboxylic acids and their use for the production of pharmaceutical agents
DE19507822B4 (en) * 1995-02-21 2006-07-20 Schering Ag Substituted DTPA monoamides of the central carboxylic acid and its metal complexes, pharmaceutical compositions containing these complexes, their use in diagnostics and therapy, and methods for the preparation of the complexes and agents
DE19507819A1 (en) * 1995-02-21 1996-08-22 Schering Ag New di:ethylene-tri:amine penta:acetic acid amide complexes
DE19507820A1 (en) * 1995-02-21 1996-08-22 Schering Ag Novel substituted DTPA derivatives, their metal complexes, pharmaceutical compositions containing these complexes, their use in diagnostics, and methods for producing the complexes and compositions
US6106866A (en) * 1995-07-31 2000-08-22 Access Pharmaceuticals, Inc. In vivo agents comprising cationic drugs, peptides and metal chelators with acidic saccharides and glycosaminoglycans, giving improved site-selective localization, uptake mechanism, sensitivity and kinetic-spatial profiles, including tumor sites
US5804164A (en) * 1996-03-13 1998-09-08 Research Corporation Technologies, Inc. Water-soluble lipophilic contrast agents
DE19646762B4 (en) * 1996-11-04 2004-05-13 Schering Ag Use of metal compounds for the production of agents for radiotherapy of tumors
DE19719033C1 (en) * 1997-04-29 1999-01-28 Schering Ag Ion pairs, processes for their preparation and their use as contrast agents
AU1770299A (en) * 1997-12-23 1999-07-19 Nycomed Imaging As Nitric oxide releasing chelating agents and their therapeutic use
IT1297035B1 (en) 1997-12-30 1999-08-03 Bracco Spa 1,4,7,10-TETRAAZACICLODODECAN-1,4-DIACETIC ACID DERIVATIVES
US7169410B1 (en) 1998-05-19 2007-01-30 Sdg, Inc. Targeted liposomal drug delivery system
ATE199557T1 (en) * 1999-09-09 2001-03-15 Schering Ag CALCIUM COMPLEX OF (4R)-4-BIS(CARBOXY- KAPPA.O)METHYL AMINO-.KAPPA.N-6,9-BIS (CARBOXY-
DE19944893C2 (en) * 1999-09-09 2001-09-20 Schering Ag Calcium complex of [[(4R) -4- [bis [(carboxy-.kappa.O) methyl] amino-. kappa.N] -6,9-bis [(carboxy-.kappa.O) methyl] -1 - [(4,4-diphenylcyclohexyl) oxy] -1-hydroxy-2-oxa-6,9-diaza-1 -phosphaundecan-11-yl-acid-.kappa.N6, .kappa.N9, .kappa.O11] 1-oxidato (6 -)] -, hexahydrogen, its salts and pharmaceutical compositions containing these complexes
US6559330B1 (en) 1999-09-09 2003-05-06 Schering Aktiengesellschaft Calcium complex of [[(4r)-4-[bis{carboxy-.kappa.o)methyl]amino-.kappa.n]-6,9-bis[(carboxy.kappa.o)methyl]-1-[(4,4-diphenylcyclohexyl)oxy]-1-hydroxy-2-oxa-6,9-diaza-1-phosphaundecan-11-ylic-acid-.kappa.n6,.kappa.n9,.kappa.011]1-oxidato(6-)]-, hexahydrogen, its salts, pharmaceutical agents that contain these complexes, their use in treatment and as additives in diagnosis, as well as processes for the production of the complexes and agents
DE19964224B4 (en) * 1999-09-09 2005-09-01 Schering Ag Pharmaceutical compositions containing calcium complex of [[(4R) -4- [bis [(carboxy-.kappa.O) methyl] amino-.kappa.N] -6,9-bis [(carboxy-.kappa.O) methyl] -1 - [(4,4-diphenylcyclohexyl) oxy] -1-hydroxy-2-oxa-6,9-diaza-1-phosphaundecan-11-yl-acid-.kappa.N6, .kappa.N9, .kappa.011] 1-oxidato (6 -)], tetrahydrogen (MS-325) and its salts, and process for their preparation
EP2277910A1 (en) 2001-12-21 2011-01-26 Human Genome Sciences, Inc. Albumin fusion proteins
DE10305462A1 (en) * 2003-02-04 2004-08-12 Schering Ag Conjugates of enantiomerically pure (4S, 8S) - and (4R, 8R) -4-p-benzyl-8-methyl-3,6,9-triaza-3N, 6N, 9N-tricarboxymethyl-1,11-undecanedioic acid with biomolecules, method for their manufacture and use for manufacture
FR2867473B1 (en) 2004-03-12 2006-06-23 Guerbet Sa PORPHYRINE COMPOUND AND HIGH FIELD USE IN MRI
CN101090739B (en) 2004-07-02 2012-10-10 伯拉考成像股份公司 1,4-bis(carboxymethyl)-6-[bis(carboxymethyl)amino]-6-methyl-perhydro-1,4-diazepine (aazta) derivatives as ligands in high relaxivity contrast agents for use in magnetic resonance imaging (mri)
WO2006124726A2 (en) 2005-05-12 2006-11-23 The General Hospital Corporation Novel biotinylated compositions
DOP2007000020A (en) 2006-01-31 2007-09-15 Bayer Schering Pharma Ag MODULATION OF THE ACTIVITY OF MDL-1 FOR THE TREATMENT OF INFLAMMATORY DISEASES
DE102007058220A1 (en) 2007-12-03 2009-06-04 Bayer Schering Pharma Aktiengesellschaft New metal complexes useful e.g. for manufacturing agent for X-ray diagnostics and magnetic resonance tomography-diagnostics of brain infarcts and liver tumor, and/or space-process in liver and abdomen tumors and musculoskeletal tumors
AU2008341050B2 (en) 2007-12-26 2013-10-24 Vaccinex, Inc. Anti-C35 antibody combination therapies and methods
US8722020B2 (en) * 2010-03-31 2014-05-13 General Electric Company Hydroxylated contrast enhancement agents
CA2883130A1 (en) 2012-08-31 2014-03-06 The General Hospital Corporation Biotin complexes for treatment and diagnosis of alzheimer's disease
CN110114093A (en) 2016-12-29 2019-08-09 创意有限责任公司 Solvent-free gadolinium contrast agent
CN106928078A (en) * 2017-02-27 2017-07-07 南昌大学 A kind of threonine chelated iron and its application
CN107632037A (en) * 2017-08-24 2018-01-26 北京中科乾和环保科技服务有限公司 Based on liquid phase31The analysis method of organophosphor in the deposit of P NMR technologies
CN112525943B (en) * 2020-11-19 2024-04-19 贵州省中国科学院天然产物化学重点实验室(贵州医科大学天然产物化学重点实验室) Q is adopted1Method for quantitatively analyzing ethanol and acetic acid in fermented fruit and vegetable juice by H-NMR technology

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US401594A (en) * 1889-04-16 Combined punch
FR1111504A (en) * 1950-03-06 1956-03-01 Cassella Farbwerke Mainkur Ag Process for the preparation of cobalt compounds
FR484M (en) * 1960-05-02 1961-05-08
FR988M (en) * 1960-12-01 1961-12-11
US3252082A (en) * 1964-01-02 1966-05-17 Chevron Res Method and composition for aiding nuclear magnetic well logging
US3818061A (en) * 1971-11-09 1974-06-18 Merck Sharp & Dohme Transparent nmr shift reagents
JPS5441575B2 (en) * 1972-07-28 1979-12-08
JPS49103693A (en) * 1973-02-02 1974-10-01
US4167564A (en) * 1974-09-23 1979-09-11 Albion Laboratories, Inc. Biological assimilation of metals
DE2527158A1 (en) * 1975-06-18 1976-12-23 Herz Eberhard MEDICINAL PRODUCTS FOR THE TREATMENT OF INFECTIOUS DISEASES AND INFLAMMATION IN HUMAN AND VETERINAL MEDICINE THAT CANNOT BE DETECTED BY MICROORGANISMS
US4066743A (en) * 1976-06-21 1978-01-03 Mallinckrodt, Inc. X-ray contrast agents
US4125599A (en) * 1976-08-19 1978-11-14 Mallinckrodt, Inc. X-ray contrast agents
US4176173A (en) * 1977-07-18 1979-11-27 Medi-Physics, Inc. Radiographic compositions
NZ188912A (en) * 1977-12-01 1984-05-31 Ici Australia Ltd Prevention or treatment of copper deficiency by topical application of copper
GB1598610A (en) * 1978-05-31 1981-09-23 Rexolin Chem Ab Aliphatic polyamino polycarboxylic acid and its salts and their use as chelating agents
JPS5759841A (en) * 1980-09-30 1982-04-10 Showa Denko Kk Treating method of waste liquor from preparation of metallic chelate of ethylenediaminetraacetic acid
US4647447A (en) * 1981-07-24 1987-03-03 Schering Aktiengesellschaft Diagnostic media
DE3129906C3 (en) * 1981-07-24 1996-12-19 Schering Ag Paramagnetic complex salts, their preparation and agents for use in NMR diagnostics
DE3518267A1 (en) * 1985-05-17 1986-11-20 Martin Prof. Dr. 1000 Berlin Wenzel Compositions for increasing contrast in magnetic resonance imaging
GB8518300D0 (en) * 1985-07-19 1985-08-29 Amersham Int Plc Contrast agent
IT1213029B (en) * 1986-01-30 1989-12-07 Bracco Ind Chimica Spa PARAMAGNETIC METAL ION CHELATES.

Cited By (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4808541A (en) * 1983-03-15 1989-02-28 Lkb Produkter Ab Determination method utilizing reagents covalently labelled with essentially non-fluorescent lanthanide chelates in combination with time-resolved fluorescence spectroscopy and the reagents to be used in the method
US4972837A (en) * 1983-04-26 1990-11-27 Regents Of The University Of California Contrast agents for nuclear magnetic resonance imaging
US4925652A (en) * 1983-08-03 1990-05-15 Schering Aktiengesellschaft Nitroxyl compounds, and diagnostic media based thereon useful for enhancing NmR imaging
AU573611B2 (en) * 1983-08-12 1988-06-16 Du Pont Merck Pharmaceutical Company, The Nmr imaging utilizing chemical shift reagents
US4615879A (en) * 1983-11-14 1986-10-07 Vanderbilt University Particulate NMR contrast agents for gastrointestinal application
US6544496B1 (en) 1983-12-21 2003-04-08 Amersham Health As Diagnostic and contrast agent
US5817291A (en) * 1983-12-21 1998-10-06 Nycomed Imaging As Method of ultrasonic imaging comprising administering biocompatible spheres or particles
US5618514A (en) * 1983-12-21 1997-04-08 Nycomed Imaging As Diagnostic and contrast agent
US5670135A (en) * 1983-12-21 1997-09-23 Nycomed Imaging As Ultrasonic contrast agent comprising carbohydrate particles
GB2177199A (en) * 1984-08-10 1987-01-14 Fox Chase Cancer Center Magnetic micro-particles as contrast agents in nuclear magnetic resonance imaging
WO1986001112A1 (en) * 1984-08-10 1986-02-27 Fox Chase Cancer Center Magnetic micro-particles as contrast agents in nuclear magnetic resonance imaging
US4749560A (en) * 1984-08-13 1988-06-07 Research Corporation Metal organo phosphorous compounds for NMR analysis
US4859450A (en) * 1984-08-13 1989-08-22 The General Hospital Corporation Method of NMR imaging using antibody to cardiac myosin
US4687658A (en) * 1984-10-04 1987-08-18 Salutar, Inc. Metal chelates of diethylenetriaminepentaacetic acid partial esters for NMR imaging
US4859451A (en) * 1984-10-04 1989-08-22 Salutar, Inc. Paramagnetic contrast agents for MR imaging
US4986980A (en) * 1984-11-01 1991-01-22 Nycomed As Water-soluble, carrier-bound paramagnetic metal containing diagnostic agents
US4985233A (en) * 1984-11-01 1991-01-15 Nycomed /As A diagnostic agent containing a non-radioactive paramagnetic metal species in a macromolecular carrier
US4687659A (en) * 1984-11-13 1987-08-18 Salutar, Inc. Diamide-DTPA-paramagnetic contrast agents for MR imaging
GB2181428A (en) * 1984-11-13 1987-04-23 New Salutar Inc Diamide-dtpa-paramagnetic contrast agents for mr imaging, apparatus and methods
WO1986002841A1 (en) * 1984-11-13 1986-05-22 New Salutar, Inc. Diamide-dtpa-paramagnetic contrast agents for mr imaging, apparatus and methods
AU583070B2 (en) * 1984-11-23 1989-04-20 Schering Aktiengesellschaft Magnetic particles for diagnostic purposes
US5089644A (en) * 1985-01-04 1992-02-18 Salutar Inc. Preparation of oxamine complexes
US4637929A (en) * 1985-01-04 1987-01-20 Salutar, Inc. Ferrioxamine-paramagnetic contrast agents for MR imaging, composition, apparatus and use
US4758422A (en) * 1985-01-04 1988-07-19 Salutar Inc. Ferrioxamine paramagnetic contrast agents for MR imaging
US4746507A (en) * 1985-04-02 1988-05-24 Salutar, Inc. EDHPA based contrast agents for MR imaging, apparatus and methods
WO1986006605A1 (en) * 1985-05-08 1986-11-20 The General Hospital Corporation Hepatobiliary nmr contrast agents
US4880008A (en) * 1985-05-08 1989-11-14 The General Hospital Corporation Vivo enhancement of NMR relaxivity
US4899755A (en) * 1985-05-08 1990-02-13 The General Hospital Corporation Hepatobiliary NMR contrast agents
US5720939A (en) * 1985-08-15 1998-02-24 Nycomed Imaging As Method of contrast enhanced magnetic resonance imaging using magnetically responsive-particles
US5010191A (en) * 1985-08-19 1991-04-23 The Regents Of The University Of California Imaging agents for in vivo magnetic resonance and scintigraphic imaging
US6143274A (en) * 1986-01-23 2000-11-07 Tweedle; Michael F. Method for imaging and radiopharmaceutical therapy using 1-substituted-4,7,10-tricarboxymethyl-1,4,7,10-tetraazacyclododecane and analogs
US5674470A (en) * 1986-01-23 1997-10-07 Bracco Diagnostics Inc. Method for imaging mammalian tissue using 1-substituted- 4,7,10-tricarboxymethyl-1,4,7,10-tetraazacyclododecane and analogs
US5474756A (en) * 1986-01-23 1995-12-12 Bracco International B.V. Method for imaging mammalian tissue using 1-substituted-1,4,7-tricarboxymethyl-1,4,7,10-tetraazacyclododecane and analogs
US5846519A (en) * 1986-01-23 1998-12-08 Bracco Diagnostics Inc. Method for imaging mammalian tissue using 1-substituted-1,4,7-tricarboxymethyl-1,4,7,10-tetraazacyclododecane and analogs
US4885363A (en) * 1987-04-24 1989-12-05 E. R. Squibb & Sons, Inc. 1-substituted-1,4,7-triscarboxymethyl-1,4,7,10-tetraazacyclododecane and analogs
US5208324A (en) * 1988-01-26 1993-05-04 Nycomed Imaging As Paramagnetic compounds
US5665328A (en) * 1988-05-02 1997-09-09 Phanos Technologies, Inc. Compounds, compositions and methods for binding bio-affecting substances to surface membranes of bio-particles
US6855309B2 (en) 1989-11-21 2005-02-15 Schering, Ag Cascade polymer bound complexing compounds, their complexes and conjugates, processes for their production, and pharmaceutical agents containing them
US7208139B2 (en) 1989-11-21 2007-04-24 Schering Ag Cascade polymer bound complexing compounds, their complexes and conjugates, processes for their production, and pharmaceutical agents containing them
US6576222B2 (en) 1989-11-21 2003-06-10 Schering Aktiengesellschaft Cascade polymer bound complexing compounds, their complexes and conjugates, process for their production and pharmaceutical agents containing them
US6193950B1 (en) 1989-11-21 2001-02-27 Schering Ag Cascade polymer bound complexing compounds, their complexes and conjugates, processes for their production, and pharmaceutical agents containing them
US7811570B2 (en) 1992-04-07 2010-10-12 Immunomedics, Inc. Method of affecting a function of or ablating a non-malignant cell
US5582814A (en) * 1994-04-15 1996-12-10 Metasyn, Inc. 1-(p-n-butylbenzyl) DTPA for magnetic resonance imaging
US7060250B2 (en) 1995-02-01 2006-06-13 Epix Pharmaceuticals, Inc. Diagnostic imaging contrast agents with extended blood retention
US7011815B2 (en) 1995-02-01 2006-03-14 Epix Pharmaceuticals, Inc. Diagnostic imaging contrast agents with extended blood retention
US7229606B2 (en) 1995-02-01 2007-06-12 Epix Pharmaceuticals, Inc. Diagnostic imaging contrast agents with extended blood retention
US6676929B2 (en) 1995-02-01 2004-01-13 Epix Medical, Inc. Diagnostic imaging contrast agents with extended blood retention
US8017105B2 (en) 1995-02-01 2011-09-13 Lantheus Medical Imaging, Inc. Diagnostic imaging contrast agents with extended blood retention
US8394356B2 (en) 1995-02-01 2013-03-12 Lantheus Medical Imaging, Inc. Diagnostic imaging contrast agents with extended blood retention
CN103664672A (en) * 2013-10-21 2014-03-26 河北一品制药有限公司 Industrial preparation method of high-purity gadopentetate dimeglumine
CN103664672B (en) * 2013-10-21 2016-01-13 河北一品制药有限公司 A kind of preparation method of suitability for industrialized production Gadopentetate Meglumine

Also Published As

Publication number Publication date
JPS5829718A (en) 1983-02-22
NL930072I1 (en) 1993-09-01
EP0169299A2 (en) 1986-01-29
JPH0768193B2 (en) 1995-07-26
EP0169299B1 (en) 1990-04-25
DE3129906A1 (en) 1983-02-10
DE3129906C3 (en) 1996-12-19
JPH0339045B2 (en) 1991-06-12
ATE52247T1 (en) 1990-05-15
NO1994031I1 (en) 1994-12-30
DE3280157D1 (en) 1990-05-31
NL930072I2 (en) 1994-01-17
AU601916B2 (en) 1990-09-20
EP0071564B1 (en) 1986-03-26
AU566007B2 (en) 1987-10-08
IE53639B1 (en) 1989-01-04
JPS62123159A (en) 1987-06-04
ATE18719T1 (en) 1986-04-15
EP0071564A1 (en) 1983-02-09
NO822546L (en) 1983-01-25
ZA825313B (en) 1983-05-25
AU1018688A (en) 1988-04-28
JPH03209389A (en) 1991-09-12
DE3270097D1 (en) 1986-04-30
NO164458C (en) 1992-11-23
IE821766L (en) 1983-01-24
EP0169299A3 (en) 1986-12-03
CA1218597A (en) 1987-03-03
NZ201372A (en) 1986-08-08
LU88291I2 (en) 1994-05-04
NO164458B (en) 1990-07-02
CA1240679A (en) 1988-08-16
JP2548436B2 (en) 1996-10-30
DE3129906C2 (en) 1990-05-17

Similar Documents

Publication Publication Date Title
AU566007B2 (en) Paramagnetic complex salts and their use in nmr- diagnostics
DE3777727D1 (en) KMR IMAGING WITH PARAMAGNETIC POLYVALENT METAL SALTS OF POLY- (ACID-ALKYLENE-AMINO) -ALKANES.
ES2121816T3 (en) PROCEDURE AND DEVICE FOR THE PREPARATION OF A CONTRAST MEANS FROM A CONCENTRATE.
GR3005807T3 (en)
IE890233L (en) Paramagnetic compounds
IL106164A0 (en) Polyazamacrocyclic compounds and their complexes with metal ions
AU7346191A (en) Method for preparing cis-beta -phenylglycidic-(2r,3r) acid
PH30222A (en) N-aralkyl-and n-hetero-aralkyl-aminoalkane phosphinic acids
DE69212627D1 (en) Process for the preparation of a homopolymer of acrylamide in microemulsion
GR3007793T3 (en)
ES2084680T3 (en) CHEMICAL CONVERSION PROCEDURE OF METAL SUBSTRATES, BATH USED IN THIS PROCEDURE AND CONCENTRATE FOR THE PREPARATION OF THE BATH.
AU557798B2 (en) Radiographic imaging composition
DE3478787D1 (en) Composition for hair-treatment
ZA929175B (en) 5,6-dihydro-dibenz(b,e)azepine-6,11-dione-11-oximes.
WAGNER LABORATORY STUDIES CONCERNING REMOBILIZATION OF PHOSPHATE FROM IRON PHOSPHATE BY COMPLEX AND PRECIPITATION REACTIONS(LABORUNTERSUCHUNGEN UEBER DIE REMOBILISIERUNG VON PHOSPHAT AUS EISENPHOSPHATE DURCH KOMPLEX-UND FAELLUNGSREAKTIONEN
NO932251L (en) CHELATING RELATIONS
AU1035092A (en) Solid glyphosate compositions and their use

Legal Events

Date Code Title Description
MK14 Patent ceased section 143(a) (annual fees not paid) or expired